Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02277249Completed
Randomised, open-label trial of digoxin, sponsored by University of California, Los Angeles. Primary endpoint: Patient Discomfort With Digoxin Injection. Started Oct 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02277249.